Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building? Sridatri Sarkar 15 hrs ago BIO's 19.1% monthly rally is backed by digital PCR gains and steadier diagnostics, but weak Life Science demand and a rich valuation loom.
Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst Sridatri Sarkar Aug 19, 2026 ABT's Medical Devices growth is fueled by electrophysiology, expanding CGM adoption and a cardiovascular pipeline extending into 2029 and beyond.
Beat the Market Like Zacks: Aveanna, FactSet, Shopify in Focus Abhinab Dasgupta Aug 10, 2026 AVAH, FDS and SHOP lead Zacks' recent standouts, with several picks posting strong gains versus the S&P 500.
Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation Sridatri Sarkar Aug 7, 2026 LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuation above the company's five-year median.
Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects Zacks Equity Research Aug 3, 2026 Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Top Analyst Reports for Microsoft, Palo Alto Networks & American Express Mark Vickery Jul 31, 2026 Microsoft rides AI, Copilot and Azure growth, but can expanding cloud demand and capacity challenges shape its next phase?
How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends Moumi Mondal Jul 31, 2026 TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key as competition intensifies.
Beat the Market Like Zacks: Monster Beverage, Carpenter Tech, Usio in Focus Abhinab Dasgupta Jul 27, 2026 MNST, CRS and USIO highlight Zacks strategies that outperformed amid a volatile market.
Company News for July 24, 2026 Zacks Equity Research Jul 24, 2026 Companies in The News Are: TMO, TSLA, UNP, CSX
TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market Zacks Equity Research Jul 23, 2026 Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.
